Zfx-induced upregulation of UBE2J1 facilitates endometrial cancer progression via PI3K/AKT pathway

References

• Lee JY, Kim JW, Lee TS, Zang R, Chen X, Yang J, Wang K-L, Sugiyama T. Difference in practice patterns in the management of endometrial cancer: a survey of the members of 4 East Asian gynecologic oncology groups. Int j gynecol cancer. 2017 Nov;27(9):1888–1894. doi: 10.1097/igc.0000000000001078. PubMed PMID: 28953133; eng.
   PubMed Web of Science ®Google Scholar
• Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW, et al. Female hormonal factors and the risk of endometrial cancer in lynch syndrome. Jama. 2015 July 7;314(1):61–71. doi: 10.1001/jama.2015.6789. PubMed PMID: 26151267; PubMed Central PMCID: PMCPmc4688894. eng.
   PubMed Web of Science ®Google Scholar
• Smits A, Lopes A, Das N, Bekkers R, Galaal K. The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol. 2014 Jan;132(1):137–141. doi: 10.1016/j.ygyno.2013.11.018. PubMed PMID: 24262880; eng.
   PubMed Web of Science ®Google Scholar
• Tseng CH. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan. Gynecol Oncol. 2015 July;138(1):147–153. doi: 10.1016/j.ygyno.2015.03.059. PubMed PMID: 25913129; eng.
   PubMed Web of Science ®Google Scholar
• Mell LK, Carmona R, Gulaya S, Lu T, Wu J, Saenz CC, Vaida F. Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study. J Natl Cancer Inst. 2013 Nov 6;105(21):1656–1666. doi: 10.1093/jnci/djt279. PubMed PMID: 24123960; PubMed Central PMCID: PMCPmc6281051. eng.
   PubMedGoogle Scholar
• Ye Y, Rape M. Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Biol. 2009 Nov;10(11):755–764. doi: 10.1038/nrm2780. PubMed PMID: 19851334; PubMed Central PMCID: PMCPmc3107738. eng.
   PubMed Web of Science ®Google Scholar
• David Y, Ziv T, Admon A, Navon A. The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. J Biol Chem. 2010 Mar 19;285(12):8595–8604. doi: 10.1074/jbc.M109.089003. PubMed PMID: 20061386; PubMed Central PMCID: PMCPmc2838281. eng.
   PubMed Web of Science ®Google Scholar
• Komander D, Rape M. The ubiquitin code. Annu Rev Biochem. 2012;81(1):203–229. doi: 10.1146/annurev-biochem-060310-170328. PubMed PMID: 22524316; eng
   PubMedGoogle Scholar
• Lester D, Farquharson C, Russell G, Houston B. Identification of a family of noncanonical ubiquitin-conjugating enzymes structurally related to yeast UBC6. Biochem Biophys Res Commun. 2000 Mar 16;269(2):474–480. doi: 10.1006/bbrc.2000.2302. PubMed PMID: 10708578; eng.
   PubMed Web of Science ®Google Scholar
• Lenk U, Yu H, Walter J, Gelman MS, Hartmann E, Kopito RR, Sommer T. A role for mammalian Ubc6 homologues in ER-associated protein degradation. J Cell Sci. 2002 July 15;115(Pt14): 3007–3014. PubMed PMID: 12082160; eng.
   PubMedGoogle Scholar
• Wu CJ, Conze DB, Li X, Ying S-X, Hanover JA, Ashwell JD. TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J. 2005 May 18;24(10):1886–1898. doi: 10.1038/sj.emboj.7600649. PubMed PMID: 15861135; PubMed Central PMCID: PMCPmc1142588. eng.
   PubMed Web of Science ®Google Scholar
• Palmer CJ, Galan-Caridad JM, Weisberg SP, Lei L, Esquilin JM, Croft GF, Wainwright B, Canoll P, Owens DM, Reizis B, et al. Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway. Cancer Res. 2014 Oct 15;74(20):5914–5924. doi: 10.1158/0008-5472.Can-14-0834. PubMed PMID: 25164012; PubMed Central PMCID: PMCPMC4199880. eng.
   PubMed Web of Science ®Google Scholar
• Chen Z, Hu H. Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA. Curr Probl Cancer. 2019 Dec;43(6):100503. doi: 10.1016/j.currproblcancer.2019.100503. PubMed PMID: 31563279; eng.
   PubMed Web of Science ®Google Scholar
• Hagihara T, Kondo J, Endo H, Ohue M, Sakai Y, Inoue M. Hydrodynamic stress stimulates growth of cell clusters via the ANXA1/PI3K/AKT axis in colorectal cancer. Sci Rep. 2019 Dec 27;9(1):20027. doi: 10.1038/s41598-019-56739-7. PubMed PMID: 31882967; PubMed Central PMCID: PMCPMC6934682 Development in Kyoto University, which is sponsored by KBBM, Inc. The other authors declare no competing interests. eng.
   PubMed Web of Science ®Google Scholar
• Si X, Xu F, Xu F, Wei M, Ge Y, Chenge S. CADM1 inhibits ovarian cancer cell proliferation and migration by potentially regulating the PI3K/Akt/mTOR pathway. Biomed pharmacother = Biomedecine pharmacotherapie. 2020 Mar;123:109717. doi: 10.1016/j.biopha.2019.109717. PubMed PMID: 31865146; eng.
   PubMed Web of Science ®Google Scholar
• Duan Q, Cai L, Zheng K, Cui C, Huang R, Zheng Z, Xie L, Wu C, Yu X, Yu J, et al. lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway. Oncol Lett. 2020 July;20(1):601–610. doi: 10.3892/ol.2020.11619. PubMed PMID: 32565985; PubMed Central PMCID: PMCPMC7286112. eng.
   PubMed Web of Science ®Google Scholar
• Yan F, Liu SW, Li XY, Li CC, Wu Y. Silencing LncRNA LINC01305 inhibits epithelial mesenchymal transition in lung cancer cells by regulating TNXB-mediated PI3K/Akt signaling pathway. J Biol Regul Homeost Agents. 2020 Mar-Apr;34(2):499–508. doi: 10.23812/20-73-a-33. PubMed PMID: 32549529; eng.
   PubMed Web of Science ®Google Scholar
• Zhang XH, Li M, Kang YJ, Xie Y-Q, Cao Y-X. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6830–6838. doi: 10.26355/eurrev_201908_18722. PubMed PMID: 31486482; eng.
   PubMed Web of Science ®Google Scholar
• Dong M, Pang X, Xu Y, Wen F, Zhang Y. Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro. Int J Mol Sci. 2013 May 24;14(6):11061–11071. doi: 10.3390/ijms140611061. PubMed PMID: 23708104; PubMed Central PMCID: PMCPMC3709718. eng.
   PubMed Web of Science ®Google Scholar
• Lin CH, Liu SY, Lee EH. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1. Oncogene. 2016 Feb 4;35(5):595–607. doi: 10.1038/onc.2015.115. PubMed PMID: 25867063; eng.
   PubMed Web of Science ®Google Scholar
• Expression of Concern: upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3b pathway. Artif Cells, Nanomed Biotechnol. 2020 Dec;48(1):747. doi: 10.1080/21691401.2020.1752024. PubMed PMID: 32285700; eng.
   PubMed Web of Science ®Google Scholar
• Xie P, Wang X, Kong M, Bai X, Jiang T. TRAF4 promotes endometrial cancer cell growth and migration by activation of PI3K/AKT/Oct4 signaling. Exp Mol Pathol. 2019 June;108:9–16. doi: 10.1016/j.yexmp.2019.03.003. PubMed PMID: 30853613; eng.
   PubMed Web of Science ®Google Scholar
• Spoelstra NS, Manning NG, Higashi Y, Darling D, Singh M, Shroyer KR, Broaddus RR, Horwitz KB, Richer JK. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res. 2006 Apr 1;66( 7):3893–3902. doi: 10.1158/0008-5472.Can-05-2881. PubMed PMID: 16585218; eng.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhou L, Lu L, Wang L, Li X, Jiang P, Chan LKY, Zhang T, Yu J, Kwong J, et al. A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma. Oncogene. 2013 July 18;32(29):3432–3442. doi: 10.1038/onc.2012.360. PubMed PMID: 22907428; eng.
   PubMed Web of Science ®Google Scholar
• Stone DM, Murone M, Luoh S, Ye W, Armanini MP, Gurney A, Phillips H, Brush J, Goddard A, de Sauvage FJ, et al. Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci. 1999 Dec;112 (Pt 23): 4437–4448. PubMed PMID: 10564661; eng.
   PubMed Web of Science ®Google Scholar
• Lemus L, Goder V. Regulation of endoplasmic reticulum-associated protein degradation (ERAD) by ubiquitin. Cells. 2014 Aug 5;3(3):824–847. doi: 10.3390/cells3030824. PubMed PMID: 25100021; PubMed Central PMCID: PMCPmc4197631. eng.
   PubMedGoogle Scholar
• Burr ML, Cano F, Svobodova S, Boyle LH, Boname JM, Lehner PJ. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2034–2039. doi: 10.1073/pnas.1016229108. PubMed PMID: 21245296; PubMed Central PMCID: PMCPmc3033308. eng.
   PubMed Web of Science ®Google Scholar
• Wen X, Li H, Sun H, Zeng A, Lin R, Zhao J, Zhang Z. MiR-455-3p reduces apoptosis and alleviates degeneration of chondrocyte through regulating PI3K/AKT pathway. Life Sci. 2020 Apr 25:117718. doi: 10.1016/j.lfs.2020.117718. PubMed PMID: 32343998; eng. 253
   PubMed Web of Science ®Google Scholar
• Liu HT, Ma RR, Lv BB, Zhang H, Shi D-B, Guo X-Y, Zhang G-H, Gao P. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer. Br J Cancer. 2020 Apr 27. doi: 10.1038/s41416-020-0836-4. PubMed PMID: 32336754; eng. 122 1825–1836
   PubMed Web of Science ®Google Scholar
• Liu HT, Ma RR, Lv BB, Zhang H, Shi D-B, Guo X-Y, Zhang G-H, Gao P. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer. Br J Cancer. 2020 June;122(12):1825–1836. doi: 10.1038/s41416-020-0836-4. PubMed PMID: 32336754; PubMed Central PMCID: PMCPMC7283217. eng.
   PubMed Web of Science ®Google Scholar
• Jiang W, Kai J, Li D, Wei Z, Wang Y, Wang W. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway. J Cell Physiol. 2020 Oct;235(10):7194–7203. doi: 10.1002/jcp.29618. PubMed PMID: 32039488; eng.
   PubMed Web of Science ®Google Scholar
• Luo LH, Jin M, Wang LQ, Xu G-J, Lin Z-Y, Yu -D-D, Yang S-L, Ran R-Z, Wu G, Zhang T, et al. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. J Cell Physiol. 2020 Sept;235(9):6154–6166. doi: 10.1002/jcp.29544. PubMed PMID: 32020591; eng.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan G, Jiang Y. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget. 2016 Mar 22;7(12):14429–14440. doi: 10.18632/oncotarget.7418. PubMed PMID: 26894862; PubMed Central PMCID: PMCPMC4924726. eng.
   PubMedGoogle Scholar
• Wang Q, Yan SP, Chu DX, Xie Y, Wang C-F, Zhang J-Y, Li W-C, Guo R-X. Silencing of long non-coding RNA RP1-93H18.6 acts as a tumor suppressor in cervical cancer through the Blockade of the PI3K/Akt Axis. Mol Ther Nucleic Acids. 2020 Mar 6;19:304–317. doi: 10.1016/j.omtn.2019.10.041. PubMed PMID: 31877407; PubMed Central PMCID: PMCPMC6938856. eng.
   PubMedGoogle Scholar
• Bjeije H, Soltani BM, Behmanesh M, Zali MR. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells. Hum Mol Genet. 2019 Oct 1;28(19):3219–3231. doi: 10.1093/hmg/ddz146. PubMed PMID: 31238337; eng.
   PubMed Web of Science ®Google Scholar
• Iovanna J, Dusetti N. Speeding towards individualized treatment for pancreatic cancer by taking an alternative road. Cancer Lett. 2017 Dec 1;410:63–67. doi: 10.1016/j.canlet.2017.09.016. PubMed PMID: 28947138; eng.
   PubMed Web of Science ®Google Scholar
• Weng H, Wang X, Li M, Wu X, Wang Z, Wu W, Zhang Z, Zhang Y, Zhao S, Liu S, et al. Zinc finger X-chromosomal protein (ZFX) is a significant prognostic indicator and promotes cellular malignant potential in gallbladder cancer. Cancer Biol Ther. 2015;16(10):1462–1470. doi: 10.1080/15384047.2015.1070994. PubMed PMID: 26230915; PubMed Central PMCID: PMCPMC4846125. eng.
   PubMed Web of Science ®Google Scholar
• Fang J, Yu Z, Lian M, Ma H, Tai J, Zhang L, Han D. Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma. Mol Cell Biochem. 2012 Jan; 360(1–2): 301–307. doi: 10.1007/s11010-011-1069-x. PubMed PMID: 22009483; eng.
   PubMed Web of Science ®Google Scholar
• Lai KP, Chen J, He M, Ching AKK, Lau C, Lai PBS, To K-F, Wong N. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma. Int J Cancer. 2014 Oct 15;135(8):1790–1799. doi: 10.1002/ijc.28819. PubMed PMID: 24585547; eng.
   PubMed Web of Science ®Google Scholar
• Wu S, Lao XY, Sun TT, Ren -L-L, Kong X, Wang J-L, Wang Y-C, Du W, Yu Y-N, Weng Y-R, et al. Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway. Cancer Lett. 2013 Sept 1;337(2):293–300. doi: 10.1016/j.canlet.2013.04.003. PubMed PMID: 23587796; eng.
   PubMed Web of Science ®Google Scholar
• Liu TY, Gong W, Tan ZJ, Lu W, Wu X-S, Weng H, Ding Q, Shu Y-J, Bao R-F, Cao Y, et al. Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX. PloS one. 2015;10(1):e0114851. doi: 10.1371/journal.pone.0114851. PubMed PMID: 25617627; PubMed Central PMCID: PMCPMC4305301. eng.
   PubMed Web of Science ®Google Scholar
• Song X, Zhu M, Zhang F, Zhang F, Zhang Y, Hu Y, Jiang L, Hao Y, Chen S, Zhu Q, et al. ZFX promotes proliferation and metastasis of pancreatic cancer cells via the MAPK pathway. Cell physiol biochem. 2018;48(1):274–284. doi: 10.1159/000491727. PubMed PMID: 30007968; eng.
   PubMedGoogle Scholar
• Rhie SK, Yao L, Luo Z, Witt H, Schreiner S, Guo Y, Perez AA, Farnham PJ. ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream of transcription start sites at the majority of CpG island promoters. Genome Res. 2018 Feb 2;28(3):310–320. doi: 10.1101/gr.228809.117. PubMed PMID: 29429977; PubMed Central PMCID: PMCPMC5848610. eng.
   PubMed Web of Science ®Google Scholar
• Han L, Wang W, Ding W, Zhang L. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7. J Cell Mol Med. 2017 Sept;21(9):2000–2008. doi: 10.1111/jcmm.13120. PubMed PMID: 28266181; PubMed Central PMCID: PMCPMC5571535. eng.
   PubMed Web of Science ®Google Scholar